BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, December 16, 2025
Home
»
Newsletters
» BioWorld
BioWorld
Jan. 3, 2008
View Archived Issues
BioWorld's Report Looks at Biotechnology Executive Pay
Read More
Other News To Note
Read More
Clinic Roundup
Read More
Bankers Say Selective Windows, Low Prices Will Continue in 2008
The window for biotech initial public offerings cracked open several times in 2007, letting out a cool burst of post-JPMorgan deals, a fresh breeze of spring offerings and a gust of fall pricings. (BioWorld Today)
Read More
Sepracor in $175M Deal with Bial for Epilepsy Drug
Read More
